NRSN
NASDAQ · Biotechnology
Neurosense Therapeutics Ltd
$1.76
-0.02 (-1.12%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,901.7% upside
Low Target
$27.84
Average Target
$35.23
High Target
$57.14
Current Price
$1.76
Current
$1.76
$1.76
Target
$35.23
$35.23
$27.84
$35.23 avg
$57.14
Scenario Analysis
Bear Case
$27.84
1,481.8%
Low target
Base Case
$35.23
+1,901.7%
Avg target
Bull Case
$57.14
+3,146.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$25.40
-93.1% from high
52-Week Low
$1.10
+60.0% from low
Target vs 52W High
$35.23
+38.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |